<DOC>
	<DOCNO>NCT00756145</DOCNO>
	<brief_summary>Low molecular weight heparin ( LMWH ) inject dialysis circuit start session . In present study compare 3 different method injection LMWH : parameter dialysis efficiency clotting measure . The study last 3 session patient .</brief_summary>
	<brief_title>The Use Low Molecular Weight Heparin Hemodiafiltration</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>chronic kidney disease stade V treat hemodiafiltration age &gt; 18 year Hematocrit &gt; 30 % treatment vitamin K antagonists treatment anticoagulant heparin besides heparin use dialysis active bleeding , infection malignancy heparin associate allergy hepatic failure trombocytopenia &lt; 120.000/Âµl</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>stage V</keyword>
	<keyword>treat</keyword>
	<keyword>hemodiafiltration</keyword>
</DOC>